Farallon Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,024,472	Closed	-$119M	–	195
2023 Q4	$119M	Buy	2,024,472 +1,023,472	+102%	+$60.1M	0.55%	40
2023 Q3	$43.6M	Buy	+1,001,000	New	+$43.6M	0.2%	60
2021 Q4	–	Sell	-238,718	Closed	-$42.2M	–	321
2021 Q3	$42.2M	Sell	238,718 -661,282	-73%	-$117M	0.2%	77
2021 Q2	$145M	Buy	900,000 +50,000	+6%	+$8.08M	0.59%	42
2021 Q1	$146M	Sell	850,000 -25,000	-3%	-$4.28M	0.72%	39
2020 Q4	$192M	Hold	875,000	–	–	1.16%	34
2020 Q3	$145M	Buy	875,000 +225,000	+35%	+$37.4M	1.01%	37
2020 Q2	$74.2M	Buy	650,000 +50,000	+8%	+$5.71M	0.59%	45
2020 Q1	$46.1M	Buy	600,000 +425,000	+243%	+$32.7M	0.4%	44
2019 Q4	$22.6M	Sell	175,000 -125,000	-42%	-$16.1M	0.15%	77
2019 Q3	$23.4M	Sell	300,000 -695,000	-70%	-$54.1M	0.18%	68
2019 Q2	$102M	Sell	995,000 -205,000	-17%	-$21.1M	0.67%	32
2019 Q1	$88M	Sell	1,200,000 -100,000	-8%	-$7.33M	0.66%	40
2018 Q4	$55.1M	Buy	1,300,000 +425,000	+49%	+$18M	0.4%	42
2018 Q3	$41.2M	Buy	875,000 +131,500	+18%	+$6.19M	0.24%	51
2018 Q2	$36.7M	Buy	743,500 +473,500	+175%	+$23.3M	0.23%	55
2018 Q1	$8.29M	Buy	+270,000	New	+$8.29M	0.06%	77